Total (n = 65) | LTOT (n = 17) | no-LTOT (n = 48) | ||||
---|---|---|---|---|---|---|
Age, years, median (IQR) | 74 (69–81) | 72 (67–78) | 74 (70–81) | |||
Men, n (%) | 38 (58.5) | 10 (58.8) | 28 (58.3) | |||
Experience as a medical worker, n (%) | 2 (3.1) | 0 (0.0) | 2 (4.2) | |||
Body mass index, median (IQR)a | 23 (19–25) | 20 (17–24) | 23 (20–26) | |||
Classification of ILD, n (%) | ||||||
IIPs | 27 (41.5) | 8 (47.1) | 19 (39.6) | |||
CTD-ILD | 34 (52.3) | 6 (35.3) | 28 (58.3) | |||
CHP | 4 (6.2) | 3 (17.6) | 1 (2.1) | |||
Composite physiologic index, median (IQR)b | 45 (31–54) | 62 (53–67) | 42 (29–51) | |||
mMRC dyspnea scale, n (%) | ||||||
0 | 13 (20.0) | 0 (0.0) | 13 (27.1) | |||
1 | 6 (9.2) | 1 (5.9) | 5 (10.4) | |||
2 | 9 (13.8) | 0 (0.0) | 9 (18.8) | |||
3 | 31 (47.7) | 12 (70.6) | 19 (39.6) | |||
4 | 6 (9.2) | 4 (23.5) | 2 (4.2) | |||
VAS score for cough, mm, median (IQR) | ||||||
Intensity | 31 (13–60) | 59 (26–67) | 28 (6–50) | |||
Frequency | 25 (5–50) | 40 (13–76) | 22 (3–49) | |||
Duration of disease, year, n (%) | ||||||
< 1 | 11 (16.9) | 0 (0.0) | 11 (22.9) | |||
1≤, < 2 | 7 (10.8) | 1 (5.9) | 6 (12.5) | |||
2≤, < 3 | 8 (12.3) | 1 (5.9) | 7 (14.6) | |||
3≤, < 4 | 3 (4.6) | 2 (11.8) | 1 (2.1) | |||
4≤, < 5 | 5 (7.7) | 2 (11.8) | 3 (6.3) | |||
≥ 5 | 31 (47.7) | 11 (64.7) | 20 (41.7) | |||
Respiratory disease-related hospitalization | ||||||
History, n (%) | 46 (70.8) | 15 (88.2) | 31 (64.6) | |||
Number, median (IQR)c | 1 (0–2) | 2 (1–4) | 1 (0–2) | |||
Acute exacerbation, n (%)c | 8 (12.5) | 2 (12.5) | 6 (12.5) | |||
Antifibrotic agents, n (%) | 12 (18.5) | 7 (41.2) | 5 (10.4) | |||
Oxygen, n (%) | ||||||
During exertion | 2 (11.8) | |||||
All of the time | 15 (88.2) |